Future directions with platelet growth factors

This publication has 26 references indexed in Scilit:

• Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia
  Leukemia Research, 1998
• Thrombopoietin levels after chemotherapy and in naturally occurring human diseases
  Current Opinion in Hematology, 1998
• Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention
  The International Journal of Cell Cloning, 1998
• The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia
  British Journal of Haematology, 1997
• ERRATUM
  Blood, 1997
• Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine
  Science, 1997
• Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer
  New England Journal of Medicine, 1997
• In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands
  Current Opinion in Hematology, 1997
• Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer
  Published by Elsevier ,1996
• Kinetics of thrombopoiesis
  Journal of Clinical Investigation, 1968